Journal of Neurology, Neurosurgery, and Psychiatry 2007;78:193-195
SHORT REPORT
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia
1 Royal Hallamshire Hospital, Sheffield, UK
2 Northern General Hospital, Sheffield, UK
3 The National Hospital for Neurology and Neurosurgery, London, UK
4 National Amyloidosis Centre, Department of Medicine, Royal Free and University College Medical School, London, UK
Correspondence to:
Correspondence to:
Dr C Douglass
Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK; chris.douglass{at}sth.nhs.uk
We report a novel transthyretin variant, Gly53Ala, in a 44-year-old British woman who presented with severe episodic headaches, often with focal neurological deficit, before developing progressive ataxia, depression, dementia and eventually peripheral neuropathy. Transthyretin amyloidosis was confirmed on biopsy of the heart muscle. Serum amyloid P component scintigraphy did not show visceral amyloid in extra-cardiac sites, but magnetic resonance imaging indicated diffuse leptomeningeal amyloidosis.
Abbreviations: CNS, central nervous system; CSF, cerebrospinal fluid; FAP, familial amyloid polyneuropathy; TTR, transthyretin
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
